Login / Signup

Current challenges in understanding the role of enhancers in disease.

Judith Barbara ZauggPelin SahlénRobin AnderssonMeritxell Alberich-JordaWouter de LaatBart DeplanckeJorge FerrerSusanne MandrupGioacchino NatoliDariusz PlewczyńskiÁlvaro Rada-IglesiasSalvatore Spicuglia
Published in: Nature structural & molecular biology (2022)
Enhancers play a central role in the spatiotemporal control of gene expression and tend to work in a cell-type-specific manner. In addition, they are suggested to be major contributors to phenotypic variation, evolution and disease. There is growing evidence that enhancer dysfunction due to genetic, structural or epigenetic mechanisms contributes to a broad range of human diseases referred to as enhanceropathies. Such mechanisms often underlie the susceptibility to common diseases, but can also play a direct causal role in cancer or Mendelian diseases. Despite the recent gain of insights into enhancer biology and function, we still have a limited ability to predict how enhancer dysfunction impacts gene expression. Here we discuss the major challenges that need to be overcome when studying the role of enhancers in disease etiology and highlight opportunities and directions for future studies, aiming to disentangle the molecular basis of enhanceropathies.
Keyphrases
  • gene expression
  • dna methylation
  • transcription factor
  • binding protein
  • endothelial cells
  • oxidative stress
  • squamous cell carcinoma
  • papillary thyroid
  • young adults
  • current status
  • case control